19.10
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$19.18
Offen:
$18.68
24-Stunden-Volumen:
5.16M
Relative Volume:
1.03
Marktkapitalisierung:
$6.89B
Einnahmen:
$8.75B
Nettoeinkommen (Verlust:
$151.00M
KGV:
50.70
EPS:
0.3767
Netto-Cashflow:
$876.00M
1W Leistung:
-2.00%
1M Leistung:
+2.36%
6M Leistung:
+50.87%
1J Leistung:
+52.43%
Nov Inc Stock (NOV) Company Profile
Firmenname
Nov Inc
Sektor
Telefon
346-223-3000
Adresse
10353 RICHMOND AVE., HOUSTON, TX
Compare NOV vs SLB, BKR, HAL, TS, FTI
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
NOV
Nov Inc
|
19.10 | 6.89B | 8.75B | 151.00M | 876.00M | 0.3767 |
|
SLB
Slb Ltd
|
52.66 | 79.05B | 35.69B | 3.45B | 4.54B | 2.3617 |
|
BKR
Baker Hughes Company
|
59.78 | 59.29B | 27.73B | 2.62B | 2.54B | 2.605 |
|
HAL
Halliburton Co
|
37.15 | 31.03B | 22.18B | 1.29B | 1.67B | 1.5088 |
|
TS
Tenaris S A Adr
|
58.61 | 29.59B | 12.00B | 1.98B | 2.02B | 3.6742 |
|
FTI
Technipfmc Plc
|
70.44 | 28.17B | 9.93B | 967.10M | 1.45B | 2.3076 |
Nov Inc Stock (NOV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-14 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-02-04 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2025-07-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-03-24 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-01-15 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-01-06 | Herabstufung | Seaport Research Partners | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Piper Sandler | Neutral |
| 2024-11-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-10-28 | Bestätigt | TD Cowen | Buy |
| 2024-09-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-07-29 | Bestätigt | TD Cowen | Buy |
| 2024-04-29 | Bestätigt | TD Cowen | Buy |
| 2024-02-05 | Bestätigt | TD Cowen | Outperform |
| 2024-01-16 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-12-08 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-10-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2023-07-14 | Eingeleitet | CapitalOne | Equal Weight |
| 2023-01-19 | Eingeleitet | The Benchmark Company | Buy |
| 2023-01-04 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-09 | Eingeleitet | Raymond James | Outperform |
| 2022-11-07 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2022-10-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-30 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-25 | Eingeleitet | The Benchmark Company | Hold |
| 2022-07-29 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-02 | Hochstufung | Griffin Securities | Neutral → Buy |
| 2022-03-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-03-11 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-23 | Herabstufung | Goldman | Neutral → Sell |
| 2022-02-07 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-09-09 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2021-07-19 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
| 2021-07-16 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-07-15 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-07-09 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2021-05-13 | Eingeleitet | Goldman | Neutral |
| 2021-01-21 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2021-01-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-01-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2021-01-06 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2020-11-10 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-10-02 | Eingeleitet | BMO Capital Markets | Underperform |
| 2020-07-29 | Bestätigt | Cowen | Outperform |
| 2020-05-14 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-04-14 | Hochstufung | Cowen | Market Perform → Outperform |
| 2020-04-07 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2020-04-06 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-03-27 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-03-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-02-19 | Herabstufung | Argus | Buy → Hold |
| 2020-02-10 | Bestätigt | Cowen | Market Perform |
| 2020-01-14 | Eingeleitet | Bernstein | Mkt Perform |
| 2019-11-05 | Bestätigt | Cowen | Market Perform |
| 2019-10-30 | Hochstufung | Goldman | Neutral → Buy |
| 2019-09-05 | Hochstufung | Jefferies | Hold → Buy |
| 2019-08-29 | Hochstufung | Johnson Rice | Hold → Buy |
| 2019-08-12 | Hochstufung | Susquehanna | Neutral → Positive |
| 2019-07-31 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-07-31 | Hochstufung | Seaport Global Securities | Sell → Neutral |
Alle ansehen
Nov Inc Aktie (NOV) Neueste Nachrichten
NOV Q1 2026 Outlook Hit by Middle East Conflict Disruptions - Yahoo Finance
BMO Capital Maintains NOV Inc(NOV.US) With Hold Rating, Raises Target Price to $21 - 富途牛牛
SIG Maintains NOV Inc(NOV.US) With Buy Rating, Maintains Target Price $22 - 富途牛牛
NOV (NYSE:NOV) Buzz Beyond Russell 1000 Index What It Really Signals - Kalkine Media
NOV Target of Unusually Large Options Trading (NYSE:NOV) - MarketBeat
NOV: Revenue Projections Amid Middle East Challenges - GuruFocus
NOV Maintained by Morgan Stanley -- Price Target Raised to $20.0 - GuruFocus
Oil-Gear Maker NOV Cuts Earnings Guidance as Iran War Hikes Costs and Snarls Deliveries - EnergyNow.com
NOV cuts Q1 guidance on Middle East war disruptions By Investing.com - Investing.com Australia
Raymond James reiterates NOV stock rating on strong balance sheet By Investing.com - Investing.com South Africa
Raymond James stays Outperform on NOV Inc. (NOV): balance sheet 'remains in great shape' - StreetInsider
Goldman Sachs reiterates NOV stock Sell rating on Middle East disruptions By Investing.com - Investing.com South Africa
Goldman Sachs reiterates NOV stock Sell rating on Middle East disruptions - Investing.com
RBC Capital maintains NOV stock rating, cuts Q1 EBITDA view on war - Investing.com Australia
Goldman Sachs on NOV Inc. (NOV): 'remain relatively conservative on the stock at present' - StreetInsider
Morgan Stanley Initiates NOV Inc(NOV.US) With Hold Rating, Announces Target Price $20 - Moomoo
NOV Inc. sees Q1 revenue, earnings below prior guidance - TipRanks
War disruptions push NOV (NYSE: NOV) Q1 2026 revenue and EBITDA below guidance - Stock Titan
NOV cuts Q1 guidance on Middle East war disruptions - Investing.com
NOV sees Q1 revenues, earnings below prior guidance on Middle East war disruptions (NOV:NYSE) - Seeking Alpha
(NOV) NOV Expects Q1 Revenue $2.05B, vs. FactSet Est of $2.05B - marketscreener.com
NOV says Middle East disruptions to weigh on first-quarter results - marketscreener.com
NOV Provides Operational Update for First Quarter 2026 - The Manila Times
Middle East conflict hits NOV deliveries, cuts Q1 revenue by $54M - Stock Titan
NOV Faces Downgrade from RBC Capital, Stock Drops 2.5% - GuruFocus
NOV Downgraded by RBC Capital -- Rating Changed to Sector Perfor - GuruFocus
NOV Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Oilfield services providers NOV, Trican Well Services downgraded at RBC (NOV:NYSE) - Seeking Alpha
RBC Capital Downgrades NOV Inc(NOV.US) to Hold Rating, Maintains Target Price $21 - 富途牛牛
RBC Downgrades NOV to Sector Perform From Outperform, Keeps $21 Price Target - marketscreener.com
NOV Inc. downgraded to Sector Perform from Outperform at RBC Capital - TipRanks
Why NOV Shares Are Sinking Amid Oil Retreat - TipRanks
RBC Capital downgrades NOV stock rating on risk/reward outlook By Investing.com - Investing.com Canada
RBC Capital Downgrades NOV Inc. (NOV) to Sector Perform - StreetInsider
Susquehanna Raises Price Target on NOV Inc. (NOV) - Insider Monkey
SG Americas Securities LLC Sells 235,131 Shares of NOV Inc. $NOV - MarketBeat
How (NOV) Movements Inform Risk Allocation Models - Stock Traders Daily
Brokerages Set NOV Inc. Price Target at $18.57 - National Today
NOV Inc. stock outperforms competitors on strong trading day - MarketWatch
3 Reasons to Sell NOV and 1 Stock to Buy Instead - Yahoo Finance
NOV Inc. (NOV) Stock Price, News, Quote & History - Yahoo! Finance Canada
[ARS] NOV Inc. SEC Filing - Stock Titan
NOV (NYSE: NOV) schedules 2026 meeting on directors, pay and EY ratification - Stock Titan
Campanelli-style ranch on Court Street in Brockton sells for $560K - Enterprise News
Nov cut to neutral at JP Morgan on macro and tariff headwinds - MSN
NOV Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
NOV Is Making A Big Bet — But The Timing Is What Stands Out - Insider Monkey
How NOV’s US$200 Million Brazil Expansion Plan Will Impact NOV (NOV) Investors - simplywall.st
NOV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Director Chowbey Sanjay files initial insider report at NOV (NOV) - Stock Titan
NOV Inc. price target raised to $22 from $21 at Susquehanna - TipRanks
Finanzdaten der Nov Inc-Aktie (NOV)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):